Back to top

Image: Bigstock

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Read MoreHide Full Article

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among the rest: earnings.

The earnings figure itself is key, of course, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb and vice versa.

Now that we know how important earnings and earnings surprises are, it's time to show investors how to take advantage of these events to boost their returns by utilizing the Zacks Earnings ESP filter.

The Zacks Earnings ESP, Explained

The Zacks Expected Surprise Prediction, or ESP, works by locking in on the most up-to-date analyst earnings revisions because they can be more accurate than estimates from weeks or even months before the actual release date. The thinking is pretty straightforward: analysts who provide earnings estimates closer to the report are likely to have more information.

With this in mind, the Expected Surprise Prediction compares the Most Accurate Estimate (being the most recent) against the overall Zacks Consensus Estimate. The percentage difference provides the ESP figure. The system also utilizes our core Zacks Rank to provide a stronger system for identifying stocks that might beat their next quarterly earnings estimate and possibly see the stock price climb.

When we join a positive earnings ESP with a Zacks Rank #3 (Hold) or stronger, stocks posted a positive bottom-line surprise 70% of the time. Plus, this system saw investors produce roughly 28% annual returns on average, according to our 10 year backtest.

Stocks with a #3 (Hold) ranking, which is most stocks covered at 60%, are expected to perform in-line with the broader market. But stocks that fall into the #2 (Buy) and #1 (Strong Buy) ranking, or the top 15% and top 5% of stocks, respectively, should outperform the market. Strong Buy stocks should outperform more than any other rank.

Should You Consider Hologic?

The final step today is to look at a stock that meets our ESP qualifications. Hologic (HOLX - Free Report) earns a #3 (Hold) eight days from its next quarterly earnings release on May 2, 2024, and its Most Accurate Estimate comes in at $0.98 a share.

HOLX has an Earnings ESP figure of +0.34%, which, as explained above, is calculated by taking the percentage difference between the $0.98 Most Accurate Estimate and the Zacks Consensus Estimate of $0.97. Hologic is one of a large database of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

HOLX is just one of a large group of Medical stocks with a positive ESP figure. Cardinal Health (CAH - Free Report) is another qualifying stock you may want to consider.

Cardinal Health is a Zacks Rank #3 (Hold) stock, and is getting ready to report earnings on May 2, 2024. CAH's Most Accurate Estimate sits at $1.98 a share eight days from its next earnings release.

The Zacks Consensus Estimate for Cardinal Health is $1.95, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of +1.11%.

HOLX and CAH's positive ESP figures tell us that both stocks have a good chance at beating analyst expectations in their next earnings report.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cardinal Health, Inc. (CAH) - free report >>

Hologic, Inc. (HOLX) - free report >>

Published in